• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Getting schooled by the Swine Flu

Getting schooled by the Swine Flu

May 21, 2009 By Tinker Ready

Lingering Swine Flu

Swine Flu continues to spread, but with few serious cases. Everyone seems less afraid. But at some schools, kids are staying home. A few schools with a lot of absent students closed this week, including Boston Latin.

My son brought home a letter from school Tuesday informing me that a handful of kids in the Cambridge system have the flu. (Cambridge — but not Boston — is in Middlesex County, home to half of the confirmed H1N1 cases in the state.) Might be Swine Flu; it might not, the letter said. Doctors have stopped testing in most cases. Still, per state order, anyone with flu symptoms was asked to stay home for seven days.

By Thursday, the city had confirmed six cases in Cambridge, including three elementary school students. Find the state’s updates here.

Thursday’s count was 193 cases, 15 hospitalized and no dead. More than half of cases are in kids under the age of 16.

And, with each flu update, the state reminds us:

“Flu outbreaks evolve in unpredictable ways; it is impossible to know whether this outbreak will decrease, remain the same, or grow in coming weeks, and whether the illness will remain at its current severity which, on the whole has been relatively mild.”

A clear eye on Washington

The Globe still has a Washington bureau and reporter Lisa Wangsness has been busy covering Congressional action on health reform. She reported Thursday that Obama probably won’t be able to deliver on his campaign promise to cut premiums by $2,500. Instead — like Medicare “cuts” — reform may limit growth, not lower costs. But, there’s a but…:

“There is, actually, a way Obama and Democratic leaders could chop premium costs very quickly: They could create a public insurance plan that would force doctors and hospitals to accept far less than they get now from private insurers. … But the will among Democrats in Congress to take such an extreme step appears low.”

Her Saturday story also mentioned the public insurance plan as deal-breaker.

A public plan is dear to the hearts of many liberals, including U.S. Senator Edward Kennedy, chairman of the health committee. But conservatives and some moderates regard it as anathema because it could sink the insurance industry. Wangsness reported Wednesday on the policy options before the Senate committee looking at reform, including a few ideas that might not work in the state’s favor.

Longwood expands and contracts

The contraction of National Institutes of Health funding is forcing Beth Israel Deaconess Medical Center to shut down some lab space, according to hospital reps quoted in Thursday’s Boston Globe:

“Hospital officials blame the projected loss on lower-than-expected NIH funding and a costly lease arrangement it made about five years ago at a new research building (the Center for Life Sciences tower) in the Longwood medical area.”

Everyone saw this coming. I wrote about the impact on NIH funding and local lab space two years ago for Nature Network Boston.

The Globe also reported that Brigham and Women’s Hospital plans to tear down an old brick mental health center on Fenwood Road and develop the site into a outpatient clinic, a mental health center and an apartment building. The paper describes it as one of last underdeveloped parcels in the Longwood Medical Area.

Fun with health information technology — an “Interoperetta”

The actual title is “HITECH: An Interoperetta in Three Acts.”

YouTube-savvy Maryland doctor Ross Martin gets barbershop trio-ish with acronyms and computer jargon. He also finds good rhymes for the names of Boston HIT heavies David Blumenthal and John Halamka, the CIO at BIDMC:

“Dr. Blumenthal, Won’t you give me a call
So I can work at the ONC (Office of the National Coordinator of HIT) …

We’ll work for Jon Halamka
As for lunch we’ll always comp ya.

Massachusetts Medicaid fraud: Two ways to rip off the poor

The Globe reported this week that a Brookline couple worth $2 million pleaded guilty to fraud and larceny charges after collecting Medicaid benefits for five family members. Joseph and Jila Youshaei reported $475 in income per week and Medicaid paid for the family’s medical bills from 1999 to 2005.

And, according to a Justice Department press release:

“The United States and 16 states have joined in two whistleblower suits filed in the District of Massachusetts against the drug manufacturer, Wyeth, alleging that the company knowingly failed to give the government the same discounts it provided to private purchasers of its drugs, as required by laws governing the Medicaid program.”

Don’t worry. Obama’s on it:

“Senior Obama administration officials launched a high-level task force yesterday to use technology to help detect and prevent health-care fraud, which robs the nation’s coffers of billions of dollars each year.”

Paul Farmer to D.C.?

Paul Farmer of Partners in Health might be headed to D.C., sources told the Globe:

“Farmer told faculty members at Harvard Medical School in a meeting on Monday that he is in discussions with the State Department, which this month proposed a surge in funding over the next six years for global programs to fight AIDS, tuberculosis, and tropical disease and to improve children’s health.”

Still no confirmation.

Women’s health heroes

“Our Bodies, Ourselves,” the feminist women’s health collective and publishers of the popular book series, announced its “2009 Womens’ Health Heroes … honoring the work of women’s health advocates worldwide.” Included are midwives and women advocating for safer, more comfortable births; founders of websites on chronic illness and teen sexuality; an activist against female genital mutilation; director of a LGBT health center; a public health nurse; a photographer; and many more.

Mass plan cost “modest”

A new analysis from policy wonks at the Massachusetts Taxpayers Foundation called the cost to taxpayers for the universal coverage program “relatively modest.”

Keep costs down and elders out of the ER

Liz Kowalczyk offered a Sunday Boston Globe story on the MGH effort to keep seniors out of the emergency room. The effort is designed to cut costs and improve care.

There’s more by Tinker Ready over at Boston Health News.

Filed Under: Healthcare Reform

In case you missed it

  • Calyxo raises $32.7M for kidney stone treatment
  • Getinge anesthesia systems recall is Class I
  • RefleXion closes $125M debt facility
  • Senseonics announces equity grants to employees
  • New data backs Aerin’s RhinAer for treating chronic rhinitis
  • Enovis completes Insight Medical acquisition
  • Orchestra BioMed to go public, partner with Medtronic on cardiac neuromodulation therapy
  • Memic Innovative Surgery is now Momentis Surgical
  • Lyra Therapeutics appoints new chief medical officer
  • Masimo’s SafetyNet monitoring reduced length of COVID-19 hospital stays, study says
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • Enovis partners with Kelvi on hot and cold therapies
  • West Pharmaceutical Services debuts new needle syringe system
  • Titan Medical names Cary G. Vance as new president, CEO
  • Acutus completes first closing in left-heart access portfolio sale to Medtronic
  • FDA clears Intuitive, Siemens Healthineers imaging integration for robotic bronchoscopy

RSS From Medical Design & Outsourcing

  • FDA can’t explain drop in device recalls, but experts point to COVID disruptions
    The FDA acknowledged interruptions with notifications from recalling firms during the pandemic, while regulatory experts point to fewer inspections and fewer procedures. FDA medical device product recalls dropped last year to their lowest level since 2013, according to a Medical Design & Outsourcing analysis of recall data from the regulatory agency. Medtech regulatory experts said the COVID-19… […]
  • DeviceTalks Boston 2022: Here’s what you missed on the show floor
    At DeviceTalks Boston 2022, there was a wealth of expertise to be had from exhibitors including Viant, ICS, PSN Labs, Propel and more. From stories of overcoming challenges during the COVID-19 pandemic to medical device materials pitfalls to avoid, MassDevice and MDO executive editor Chris Newmarker hit the DeviceTalks Boston show floor to discover insights. […]
  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS